HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation

Human Immunology

Volumn 71, Issue 9, 2010, Pages 851-856

  Kosmoliaptsis, Vasilis ^a,b   Sharples, Linda D ^c   Chaudhry, Afzal ^a   Johnson, Rachel J ^d   Fuggle, Susan V ^d,e   Halsall, David J ^a   Bradley, J Andrew ^b   Taylor, Craig J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Amino acid sequence; HLA matching; Kidney transplantation

Indexed keywords

ALLOANTIGEN; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CADAVER KIDNEY; GENE LOCUS; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HYDROPHOBICITY; IMMUNOGENICITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS; CHILD; CHILD, PRESCHOOL; GRAFT SURVIVAL; GREAT BRITAIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INFANT; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; STATIC ELECTRICITY; TISSUE DONORS; YOUNG ADULT;

EID: 77956011276     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.06.003     Document Type: Article

References (26)

1. Morris P.J., Johnson R.J., Fuggle S.V., Belger M.A., Briggs J.D. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999, 354:1147-1152.
2. Opelz G., Wujciak T., Döhler B., Scherer S., Mytilineos J.Hla. Compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999, 1:334-342.
3. Takemoto S.K., Terasaki P.I., Gjertson D.W., Cecka J.M. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000, 343:1078-1084.
4. Cecka J.M. The UNOS. Renal transplant registry. Clin Transpl 2002, 1-20.
5. Opelz G., Dohler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007, 84:137-143.
6. Taylor C.J., Welsh K.I., Gray C.M., Bunce M., Bayne A.M., Sutton P.M., et al. Clinical and socio-economic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens in a single unit. Clinical Transplants 1993, UCLA, Los Angeles, CA, Tissue Typing Laboratory 1994. P.I. Terasaki, J.M. Cecka (Eds.).
7. Fuggle S.V., Johnson R.J., Rudge C.J., Forsythe J.L. Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom. Transplantation 2004, 77:618-620.
8. Fuggle S.V., Johnson R.J., Bradley J.A., Rudge C.J. Impact of the 1998 UK National Allocation Scheme for Deceased Heartbeating Donor Kidneys. Transplantation 2010, 89:372-378. Kidney Advisory Group of NHS Blood and Transplant.
9. Johnson R.J., Fuggle S.V., O'Neill J., Start S., Bradley J.A., Forsythe J.L., et al. Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: An evidence base for a new national kidney allocation policy. Transplantation 2010, 89:379-386. Kidney Advisory Group of NHS Blood and Transplant.
10. Johnson R.J., Fuggle S.V., Mumford L., Bradley J.A., Forsythe J.L., Rudge C.J. A new UK 2006 national kidney allocation scheme for deceased heart-beating donor kidneys. Transplantation 2010, 89:387-394. Kidney Advisory Group of NHS Blood and Transplant.
11. Taylor C.J., Dyer P.A. Maximising the benefits of HLA matching for renal transplantation; alleles, specificities, CREGs, epitopes or residues?. Transplantation 1999, 68:1093-1094.
12. Opelz G. Importance of HLA antigen splits for kidney transplant matching. Lancet 1988, 2:61-64.
13. Opelz G., Scherer S., Mytilineos J. Analysis of HLA-DR split-specificity matching in cadaver kidney transplantation: A report of the Collaborative Transplant Study. Transplantation 1997, 63:57-59.
14. Doxiadis S.J.M., Schreuder G.M., Persijn G.G., van Houwelingen H.C., van Rood J.J., et al. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet 1996, 348:850-853.
15. Maruya E., Takemoto S., Terasaki P.I. HLA matching: Identification of permissible HLA mismatches. Clin Transpl 1993, 25:511-520.
16. Wujciak T., Opelz G. Evaluation of the permissible mismatch concept. Transpl Int 1996, 9(Suppl 1):S8-S10.
17. Duquesnoy R.J. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002, 63:339-352.
18. Duquesnoy R.J., Marrari M. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 2002, 63:353-363.
19. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67:847-862.
20. Duquesnoy R.J., Howe J., Takemoto S. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation 2003, 75:889-897.
21. Goodman R.S., Taylor C.J., O'Rourke C.M., Lynch A., Bradley J.A., Key T. Utility of HLAMatchmaker and single-antigen HLA antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Transplantation 2006, 81:1331-1336.
22. Kosmoliaptsis V., Bradley J.A., Sharples L.D., Chaudhry A., Key T., Goodman R.S., Taylor C.J. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008, 85:1817-1825.
23. Duquesnoy R.J., Takemoto S., de Lange P., Doxiadis S.G.M., Persijn G.G., Persijn G.G., Claas F.H. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation 2003, 75:884-889.
24. Laux G., Mytilineos J., Opelz G. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Transplantation 2004, 77:902-907.
25. Kosmoliaptsis V., Chaudhry A.N., Sharples L.D., Halsall D.J., Dafforn T.R., Bradley J.A., Taylor C.J. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2009, 88:791-798.
26. Dankers M.K., Witvliet M.D., Roelen D.L., de Lange P., Korfage N., Persijn G.G., et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004, 77:1236-1239.